Clinical trial

A Study Comparing the Efficacy and Safety of Intracoronary Stenting With or…

NCT00271401 · Centocor, Inc., Industry · Completed

Key facts

NCT number NCT00271401
Title A Study Comparing the Efficacy and Safety of Intracoronary Stenting With or Without Abciximab, an Anti-Platelet Therapy, and Conventional Coronary Angioplasty With Abciximab
Official title A Multicenter, Randomized Trial Evaluating 30-day and 6-month Clinical Outcomes With Three Different Treatment Strategies (Coronary Angioplasty + Abciximab, Intracoronary Stent + Abciximab, and Intracoronary Stent + Placebo) in Patients Undergoing Percutaneous Coronary Intervention
Lead sponsor Centocor, Inc., Industry
Status Completed
Phase Phase 3
Study type Interventional
Conditions Angioplasty, Transluminal, Percutaneous Coronary
Intervention type Drug, Other
Interventions Angioplasty, Intracoronary Stent, Abxicimab, Heparin, Placebo
Enrollment 2,399
Start date Jul 1, 1996
Primary completion Sep 1, 1997
Completion Sep 1, 1997
First posted Jan 2, 2006
Last update posted May 25, 2015

At a glance

  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies